4//SEC Filing
Kyrillos Jean-Claude 4
Accession 0001438133-26-000003
CIK 0001438133other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:09 PM ET
Size
8.9 KB
Accession
0001438133-26-000003
Insider Transaction Report
Form 4
Kyrillos Jean-Claude
EVP & Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-15+3,636→ 26,180 total - Tax Payment
Common Stock
[F1]2026-01-15$21.07/sh−2,118$44,626→ 24,062 total - Exercise/Conversion
Restricted Stock Unit
[F2][F3][F4]2026-01-15−3,636→ 21,817 total→ Common Stock (3,636 underlying)
Footnotes (4)
- [F1]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F3]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Signature
/s/ Shannon M. Hansen, Attorney-in-Fact for Jean-Claude Kyrillos|2026-01-20
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001804186
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:09 PM ET
- Size
- 8.9 KB